PhRMA comments in response to request for information on competitive bidding program in Medicare Part B

Yesterday, the Pharmaceutical Research and Manufacturers of America (PhRMA) submittedcomments in response to the recent 2019 Hospital Outpatient Prospective Payment System proposed rule, including the request for information (RFI) regarding the creation of a competitive acquisition program (CAP) in Medicare Part B through the Center for Medicare& Medicaid Innovation (CMMI). In the comments, PhRMA raised a couple key areas for the Administration to consider before moving forward on any CAP proposal, including:
Source: The Catalyst - Category: Pharmaceuticals Tags: Medicare Part B CMMI Source Type: news